Teva Investigational Site 10721 — Winston-Salem, North Carolina

Teva Investigational Site 10721 is a clinical research site located in Winston-Salem, North Carolina, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Teva Investigational Site 10721 has participated in 1 clinical trials.

Therapeutic areas: Relapsing-Remitting Multiple Sclerosis.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 10721?

Teva Investigational Site 10721 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 10721 conducted?

Teva Investigational Site 10721 has 1 clinical trials on record. Their work covers Relapsing-Remitting Multiple Sclerosis.

Is Teva Investigational Site 10721 accredited by Crixeo Health?

Teva Investigational Site 10721 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 10721?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.